News Release

Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder
K. Y. Wu, I. T. Hsiao, C. H. Chen, C. Y. Liu, J. L. Hsu,  S. Y. Huang, T. C. Yen, K. J. Lin,"...
more
Characterization of magnetic relaxation when biofunctionalized magnetic nano-particles are associated with biomarkers in the liquid state in biomedical applications
S. H. Liao, H. S. Huang, J. H. Chen, Y. K. Su and Y. F. Tong, " Characterization of magnetic...
more
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
C. C. Yang,M. J. Chiu, T. F. Chen, H. L Chang, B. H. Liu, S. Y Yang,"Assay of Plasma Phosphorylated...
more
Potential applications of magnetic particles to detect and treat Alzheimer's disease
M. A. Busquets, R. Sabaté, and J. Estelrich, “Potential applications of magnetic particles to...
more
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
A. L. Baird, S. Westwood, and S. Lovestone, “Blood-Based Proteomic Biomarkers of Alzheimer's...
more

Pages